These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 963962

  • 1. [Therapeutic report on an injectable aldosterone antagonist (K-canrenoate) in states of water-salf retention].
    Coltorti M, Radaeli E, Ciaccio S, Corsini R, Trebbi R.
    Clin Ter; 1976 Feb 15; 76(3):215-34. PubMed ID: 963962
    [No Abstract] [Full Text] [Related]

  • 2. [Indication and experience with an intravenously administered aldosterone-antagonist (soldactone) (author's transl)].
    Kirsch R.
    Schweiz Rundsch Med Prax; 1975 Nov 04; 64(44):1414-7. PubMed ID: 1236699
    [No Abstract] [Full Text] [Related]

  • 3. [Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites].
    Traina M, Vizzini GB.
    Minerva Med; 1986 Jan 28; 77(3-4):87-91. PubMed ID: 3511409
    [Abstract] [Full Text] [Related]

  • 4. [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].
    Tempini S, Bellati G, Ideo G.
    Minerva Dietol Gastroenterol; 1984 Jan 28; 30(3):255-61. PubMed ID: 6504374
    [No Abstract] [Full Text] [Related]

  • 5. [Use of canrenoate potassium given orally in ascitogenic cirrhosis].
    Sarti F, Milandri GL, Piemontese A, Macchia S, Simoni S, Dal Monte PR.
    Minerva Dietol Gastroenterol; 1984 Jan 28; 30(3):273-80. PubMed ID: 6504377
    [No Abstract] [Full Text] [Related]

  • 6. [Use of potassium canrenoate in cardiosurgery].
    Tufano R, Scopa M, Brando G, Leone D.
    Minerva Anestesiol; 1981 Apr 28; 47(4):149-54. PubMed ID: 7242963
    [Abstract] [Full Text] [Related]

  • 7. [Effect of canrenoate potassium on intraoperative disturbances of electrolyte equilibrium].
    Eschner J, Fodor L, Ahnefeld FW.
    Infusionsther Klin Ernahr; 1976 Apr 28; 3(2):98-104. PubMed ID: 965083
    [Abstract] [Full Text] [Related]

  • 8. [Use of an aldosterone antagonist in abdominal surgery].
    Ribero F, Remonda G, Morachioli N, Pugnani M.
    Ann Osp Maria Vittoria Torino; 1982 Apr 28; 25(1-6):61-70. PubMed ID: 7185311
    [Abstract] [Full Text] [Related]

  • 9. [The use of an injectable anti-aldosteron agent in the treatment of secondary hyperaldosteronism].
    Tartagni F, Ambrosioni E.
    Boll Soc Ital Cardiol; 1976 Apr 28; 21(4):725-7. PubMed ID: 1031037
    [No Abstract] [Full Text] [Related]

  • 10. [Potassium canreonate in neurosurgical brain edema].
    Mille T, Rodriguez R, Baena Y.
    Minerva Chir; 1976 Apr 28; 30(13-14):781-9. PubMed ID: 1221307
    [Abstract] [Full Text] [Related]

  • 11. [Therapeutic effect of canrenoate potassium (soldactone) in patients after open-heart surgery].
    Matsuda K, Tatsuta N, Konishi Y, Minami K, Nishiwaki N, Yamasato A, Chiba Y, Ishihara H, Murata S, Shiraishi Y, Muraguchi T, Hikasa Y.
    Nihon Geka Hokan; 1982 May 01; 51(3):519-27. PubMed ID: 7138201
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical experience with the use of a new drug: "ethacrynic acid"].
    Cicconetti C, Cantera N.
    Policlinico Prat; 1969 Jan 01; 76(3):69-78. PubMed ID: 5763598
    [No Abstract] [Full Text] [Related]

  • 13. [Brain edema in neurosurgery. Trial with an aldosterone-antagonist (soldactone) (author's transl)].
    Anderes JP, de Tribolet N, Zander E.
    Schweiz Rundsch Med Prax; 1977 Aug 09; 66(32):1020-6. PubMed ID: 556440
    [No Abstract] [Full Text] [Related]

  • 14. High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism.
    Radó JP, Marosi J, Takó J.
    Endokrinologie; 1970 Aug 09; 57(1):46-62. PubMed ID: 4923990
    [No Abstract] [Full Text] [Related]

  • 15. [Disorders of water and electrolyte equilibrium in liver diseases. Part 3: therapy (author's transl)].
    Kuntz E.
    MMW Munch Med Wochenschr; 1982 May 14; 124(19):465-7. PubMed ID: 6810108
    [No Abstract] [Full Text] [Related]

  • 16. [Plasma hyperosmolarity aspects in intensive care and its treatment with potassium canreonate].
    Ruggerini R, Mazzocchi F, Albini G, Cifalinò M.
    Minerva Anestesiol; 1979 Sep 14; 45(9):687-90. PubMed ID: 117400
    [Abstract] [Full Text] [Related]

  • 17. [Clinical experience in the use of Osyrol 100 and Osyrol for injection (author's transl)].
    Gorbach HC, Bräuninger HJ.
    MMW Munch Med Wochenschr; 1975 Sep 14; 117(37):1483-6. PubMed ID: 810673
    [Abstract] [Full Text] [Related]

  • 18. Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over.
    Emili M, Cuppone R, Ricci GL.
    Arzneimittelforschung; 1988 Oct 14; 38(10):1492-5. PubMed ID: 3058132
    [Abstract] [Full Text] [Related]

  • 19. [Clinical trials of ethacrynic acid].
    Laroche C, Grégoire J.
    Sem Hop; 1967 Jun 08; 43(28):1845-50. PubMed ID: 4294301
    [No Abstract] [Full Text] [Related]

  • 20. [Effectiveness of K canrenoate in the treatment of secondary hyperaldosteronism].
    Tartagni F, Pasetti L, Ambrosioni E, Magnani B.
    G Clin Med; 1979 Mar 08; 60(3):196-206. PubMed ID: 520727
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.